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RESEARCH ARTICLE
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Abstract
Background
Nontyphoidal Salmonellae (NTS) cause a large burden of invasive and gastrointestinal dis-
ease among young children in sub-Saharan Africa. No vaccine is currently available. Previ-
ous reports indicate the importance of the O-antigen of Salmonella lipopolysaccharide for
virulence and resistance to antibody-mediated killing. We hypothesised that isolates with
more O-antigen have increased resistance to antibody-mediated killing and are more likely
to be invasive than gastrointestinal.
Methodology/Principal Findings
We studied 192 NTS isolates (114 Typhimurium, 78 Enteritidis) from blood and stools,
mostly from paediatric admissions in Kenya 2000–2011. Isolates were tested for suscepti-
bility to antibody-mediated killing, using whole adult serum. O-antigen structural characteris-
tics, including O-acetylation and glucosylation, were investigated. Overall, isolates were
susceptible to antibody-mediated killing, but S. Enteritidis were less susceptible and ex-
pressed more O-antigen than Typhimurium (p<0.0001 for both comparisons). For S. Typhi-
murium, but not Enteritidis, O-antigen expression correlated with reduced sensitivity to
killing (r = 0.29, 95% CI = 0.10-0.45, p = 0.002). Both serovars expressed O-antigen popula-
tions ranging 21–33 kDa average molecular weight. O-antigen from most Typhimurium
were O-acetylated on rhamnose and abequose residues, while Enteritidis O-antigen had
low or no O-acetylation. Both Typhimurium and Enteritidis O-antigen were approximately
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20%–50% glucosylated. Amount of S. Typhimurium O-antigen and O-antigen glucosylation
level were inversely related. There was no clear association between clinical presentation
and antibody susceptibility, O-antigen level or other O-antigen features.
Conclusion/Significance
Kenyan S. Typhimurium and Enteritidis clinical isolates are susceptible to antibody-
mediated killing, with degree of susceptibility varying with level of O-antigen for S. Typhimur-
ium. This supports the development of an antibody-inducing vaccine against NTS for Africa.
No clear differences were found in the phenotype of isolates from blood and stool, suggest-
ing that the same isolates can cause invasive disease and gastroenteritis. Genome studies
are required to understand whether invasive and gastrointestinal isolates differ at the
genotypic level.
Author Summary
Nontyphoidal Salmonellae (NTS) are an emerging major cause of invasive bacterial disease
in African children aged less than 5 years and immunocompromised adults, with an esti-
mated case fatality rate of 20–25%. NTS also cause diarrhoea, a killer of about 1.5 million
young children annually, mainly in low- and middle-income countries. No vaccine against
NTS is available, but improved understanding of the Salmonella bacteria that cause disease
in Africa would help the development of new vaccines. The authors characterized a collec-
tion of 192 Kenyan NTS strains (114 S. Typhimurium and 78 S. Enteritidis) from blood
and stool specimens. All strains could be killed to differing extents by antibodies present
in the blood of healthy HIV-uninfected African adults, supporting the development of a
vaccine that will induce protective antibodies when given to African children. Differences
in killing by antibody were partly related to the amount of O-antigen on the bacterial sur-
face. There were no clear distinction between stains causing invasive disease and diar-
rhoea, suggesting that the same strains may be capable of causing both forms of disease.
Clarification of this will require genomic analysis.
Introduction
NTS are a major but neglected cause of invasive disease (hence iNTS disease) in Africa [1–3].
Salmonella enterica serovars Typhimurium and Enteritidis account for nearly 80% of all
human isolates reported globally [4]. While in developed countries, these predominantly cause
a mild self-limiting gastroenteritis [5–7], in Africa they are responsible for bacteraemia, often
associated with meningitis in young children, with incidence rates comparable to invasive S.
pneumoniae disease [3]. The true burden of iNTS disease is uncertain due to the absence of a
characteristic clinical presentation. Patients often present with nonspecific fever [8–10] and
blood culture is necessary for diagnosis. Even where blood culture facilities are available, rapid
clinical progression of NTS bacteraemia results in many patients dying before a microbiological
diagnosis can be made [10]. No vaccine is available, and clinical management is made
difficult by widespread multi-drug resistance and the need for late-generation expensive
antibiotics [11–13].
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In Kenya, iNTS disease is particularly frequent in rural areas [14], with incidence rates as
high as 568/100,000 person-years [15]. A recent study fromWestern Kenya found an associa-
tion between NTS diarrhoea and mortality in hospitalized children [16], indicating that NTS
isolates in the region can cause fatal invasive and gastrointestinal disease, but it is currently un-
known whether specific microbial phenotypic or genotypic characteristics are associated with
each clinical presentations. Whole genome sequencing studies demonstrate that invasive Afri-
can S. Typhimurium are genetically distinct from those in the rest of the world, and are charac-
terized by a new sequence type, ST313, that has spread throughout the continent [17]. The
ST313 pathovar is associated with genome degradation and pseudogene accumulation [13].
Equivalent studies are ongoing for S. Enteritidis which is more prevalent than S. Typhimurium
in some parts of Africa [18,19], and globally [20]. Investigation of the relationship between ge-
notypic and phenotypic features of Typhimurium isolates is ongoing and a systematic charac-
terization of endemic Typhimurium and Enteritidis isolates from one endemic region
is awaited.
Lipopolysaccharide (LPS) forms the outer layer of Salmonella and other Gram-negative bac-
teria, and is key to the interaction between Salmonella and its environment. The O-antigen
chain (including core sugars, hereafter referred to as ‘OAg’) constitutes the outermost part of
LPS [21]. In pathogenic bacteria such as Salmonella, LPS plays an important role in the interac-
tion between the bacterium and its host and is a virulence factor required for colonization and
resistance to antibody-mediated killing [22]. While the lipid A moiety is the predominant
cause of the endotoxic effects of LPS, OAg is the most immunodominant portion of the mole-
cule, and is responsible for serovar-specificity [23]. OAg protects bacteria from the environ-
ment and from serum complement [24–26], which can lead to bacterial killing by membrane
attack complex formation. Rough strains of Salmonella that lack OAg are avirulent and suc-
cumb readily to complement-mediated killing [26]. The OAg structure plays a role in bacterial
virulence, with longer OAg chains associated with increased complement and antibody resis-
tance [27–29] and protection against other host antimicrobial factors [30].
In this study we analysed a bacterial collection of 114 S. Typhimurium and 78 S. Enteritidis
isolates derived from patients, mostly children, presenting to three main Kenyan hospitals in
Nairobi and from 31 healthy carriers related to these patients. Our primary objective was to
characterise NTS isolates circulating in endemic areas, with the goal of identifying bacterial fea-
tures associated with either invasive or gastrointestinal pathology. We hypothesised that inva-
sive isolates would, by nature, be more resistant to survival in the blood than gastrointestinal
isolates, and focused our analysis on the susceptibility of isolates to antibody-mediated killing
and characterization of the OAg expressed by the various isolates. We investigated the total
amount of OAg expressed by the various isolates and OAg specific characteristics such as mo-
lecular weight (MW), O-acetylation and glucosylation levels, parameters which can influence
OAg immunogenicity. Additionally, we tested the sensitivity of the isolates to antibody killing,
using whole human serum from HIV-uninfected adults [31]. The results obtained were com-
pared with clinical presentation in order to identify possible associations.
Materials and Methods
Origin of bacterial isolates and serum samples
The study culture collection contained 192 archived NTS isolates (114 S. Typhimurium and 78
S. Enteritidis) collected between 2000 and 2011 at the Centre for Microbiology Research
(CMR), Kenya Medical Research Institute (KEMRI) in Nairobi, Kenya. Study isolates were se-
lected from the archived bacterial culture collection based on availability of unequivocal sero-
var identification and availability of clinical records and metadata. The isolates were stored in
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Tryptic Soy Broth with 15% glycerol at-80°C. The isolates were from blood and stools with a
few additional samples from urine (3 samples), cerebrospinal fluid (CSF, 2 samples) and envi-
ronmental sources (2 samples). The isolates were mostly from children admitted to three main
hospitals in Nairobi county, namely: Kenyatta National Referral hospital, Gertrude’s Children’s
Hospital and Aga Khan University Hospital. This collection also included isolates from healthy
carriers (31 samples). Before use in the present study, the archived isolates were re-cultured
and the serotype was confirmed by antibody-based agglutination (Bio-Rad Laboratories, Inc.,
Hercules, CA, USA).
Based on the clinical sources and sample type, the NTS isolates were divided into four main
groups. Those isolates from body fluids that are normally sterile such as blood and CSF were
grouped as ‘invasive’, those from stool samples of patients were grouped as ‘gastroenteric’,
those from stool samples of healthy individuals were grouped as ‘healthy carriers’ while those
from soil and sewer water sources were grouped as ‘environmental’. The three isolates from
urine samples were considered clinically significant invasive sterile site isolates since Salmonel-
lae are not part of the normal perineal skin flora and the isolates were from patients with symp-
toms of urinary tract infection.
Undiluted sera from ten healthy HIV-uninfected Malawian adults were used to generate a
pooled serum to assess sensitivity to antibody-mediated killing of the Salmonella isolates. Each
serum was tested prior to pooling to ensure that killing of the index S. Typhimurium ST313
strain, D23580, was within the 0.9 to 3.0 Log10 range previously described for such sera [32].
Sera were handled at 4°C during the pooling process to ensure preservation of endogenous
complement activity and frozen in aliquots at-80°C. Ethical approval for preparation of this
serum was granted by the College of Medical Research and Ethics Committee, College of Medi-
cine, University of Malawi [31].
Serum Bactericidal Activity (SBA) assay
The study isolates were tested for their susceptibility/resistance to killing against the serum
pool described above, using a protocol involving whole serum and endogenous complement
activity as previously described [26]. Briefly, 5 μl washed bacteria at 2 h log-growth phase at an
OD of approximately 0.2 (with shaking at 180 rpm) was added to 45 μl undiluted serum at a
final bacterial concentration of 1×106 colony forming units, CFU/ml and incubated at 37°C
with the number of viable bacteria count determined by serial dilution on Luria Bertani (LB)
agar after 0 and 180 min. As a negative control, reference sera were heat-inactivated at 56°C for
45 min to inactivate endogenous complement and included in each SBA experiment. Addition-
al internal controls included testing the representative endemic African S. Typhimurium isolate
D23580, previously shown to be susceptible to serum killing [26] and hyperimmune mouse
serum containing high levels of anti-OAg antibodies [33]. Susceptibility to serum killing was
determined as any reduction in viable bacterial count compared with the initial
Salmonella concentration.
O-antigen extraction and quantification
OAg extraction was performed by acid hydrolysis [34]. Bacterial isolates were grown overnight
in LB medium. As OAg expression can be influenced by growth conditions, identical condi-
tions were used for the growth of all strains [29]. The bacterial OD was measured and the bac-
terial cultures were concentrated in PBS to OD: 35. Acetic acid (2% v/v) was then added to the
concentrated growth bacterial culture (pH 3), which were incubated for 3h at 100°C. The reac-
tion was stopped by the addition of 14% ammonium hydroxide, increasing the pH to around 6.
Bacterial debris was removed by centrifugation and OAg in the supernatant was 0.22 μm
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microfiltered and desalted by HiTrap Desalting 5 ml columns (GE Healthcare, UK).
Phenol sulphuric acid assay, using glucose as standard, was used for quantification of OAg
content [34,35].
1H Nuclear Magnetic Resonance Spectroscopy (1H NMR)
1H NMR analysis was performed as a confirmation of the identity of the OAg samples and to
verify the presence of O-acetyl groups along the OAg chain as previously described [34].
High Performance Anion Exchange Chromatography with Pulsed
Amperometric Detection (HPAEC-PAD)
Glucosylation level of OAg samples was estimated by HPAEC—PAD after acid hydrolysis of
the OAg to release the monosaccharides constituting the sugar chain as described previously.
Commercial glucose was used for building the calibration curve (0.5–10 μg/ml). Glucose (Glc)
level is calculated as molar ratio of Glc to rhamnose (Rha), sugar present in each OAg repeating
unit. The analysis was also used as confirmation of the OAg samples identity verifying the cor-
rect monosaccharides ratios in the repeating unit [34,36].
Size-exclusion High-Performance Liquid Chromatography (HPLC-SEC)
HPLC—SEC analysis was used to estimate the molecular size distribution of OAg populations
[34,36]. Samples were run, without pre-treatment, on a TSK gel G3000 PWXL column (30 cm
x_7.8 mm; particle size 7 um; cod. 808021) with a TSK gel PWXL guard column (4.0 cm _x 6.0
mm; particle size 12 um; cod. 808033) (Tosoh Bioscience, Tokyo, Japan). The mobile phase
was 0.1 M NaCl, 0.1 M NaH2PO4, 5% CH3CN, pH 7.2, at the flow rate of 0.5 ml/min (isocratic
method for 30 min). OAg peaks were detected by differential refractive index (dRI). Void and
bed volume calibration was performed with λ-DNA (λ-DNA molecular weight (MW) Marker
III 0.12–21.2 kb; Roche) and sodium azide (Merck, New Jersey, USA), respectively. OAg aver-
age MWwas estimated on standard dextrans (Sigma) calibration curve.
Statistical analyses
Serum susceptibility and OAg amounts of the two Salmonella serovars examined (S. Typhi-
murium and S. Enteritidis) was compared using the Mann-Whitney U test. Possible correla-
tions (i.e. OAg amount and serum susceptibility, glucosylation levels and OAg production)
were analysed by Spearman rank.
Results
NTS bacterial collection
Of the 192 NTS isolates in the study, 114 (59%) were S. Typhimurium and 78 (41%) were S.
Enteritidis. This study collection included isolates from blood, stools (patients and healthy con-
tacts), CSF, urine and environmental/animal sources as described in Table 1 (see S1a-b Table
for supporting information). The isolates were obtained from hospitals based in Nairobi, an
urban setting. Clinical information on patients’ age was available for 67% of cases (73 with S.
Typhimurium, 57 with S. Enteritidis). The age ranged from 1 month to 59 years for S. Typhi-
murium isolates and 0 months to 64 years for S. Enteritidis isolates, the majority (65%, 85 iso-
lates) of these patients being below 5 years (53 S. Typhimurium, 32 S. Enteritidis). Overall, the
median age of subjects from whom S. Typhimurium and S. Enteritidis strains were isolated was
2 and 3.5 years, respectively. Ages were not available for the healthy carriers.
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SBA results
SBA results using the serum pool demonstrated a marked difference in susceptibility to anti-
body-mediated killing among individual isolates and a clear difference in susceptibility between
S. Typhimurium and S. Enteritidis isolates (Fig. 1, and see S2a and S2b Table for supporting in-
formation).). We have previously demonstrated that this killing is through the antibody-
dependent complement-mediated mechanism and requires the presence of specific antibodies
and intact complement function [26]. We have also demonstrated that the control sera used in
this assay from healthy Malawian adults contains abundant antibody levels to NTS [32]. All ex-
cept one S. Typhimurium isolate (0.9%, 1/114) underwent a reduction in viable bacterial counts
over the 180 minute time course of the assay, and so were designated ‘sensitive’ to antibody-
mediated killing. Overall median Log10 reduction in viable bacteria after 180 minutes was 2.9
for S. Typhimurium. Indeed 50% (57/114) S. Typhimurium were highly susceptible to killing,
undergoing a 3.0 Log10 reduction. In contrast S. Enteritidis as a group were less susceptible to
antibody-mediated killing than S. Typhimurium, being killed by a median of 1.2 Log10
(p<0.0001, MannWhitney test). However, all S. Enteritidis were sensitive to killing. A small
proportion (10.3%, 6/78) was killed by a full 3.0 Log10.
OAg characterization
OAg was extracted from all 192 NTS study isolates normalized to the same final OD and total
amount was quantified by phenol sulphuric acid assay [34]. NTS isolates produced a range of
OAg amounts, with low (<10 μg/ml/OD) and high producers (>25 μg/ml/OD). On average, S.
Enteritidis isolates expressed more OAg than S. Typhimurium, with 70.9% of the isolates pro-
ducing more than 15 μg/ml/OD OAg compared to only 42.1% S. Typhimurium. Median OAg
production for S. Enteritidis isolates was 16.8 μg/ml/OD compared to 14.4 μg/ml/OD of S.
Typhimurium (p<0.0001 by MannWhitney test) (Fig. 2). All study isolates contained one sin-
gle main OAg population with average MW of 21–33 kDa (Fig. 3a);<5% isolates contained
OAg population with average MW< 6 kDa.
NMR analysis on a set of 118 samples (73 S. Typhimurium and 45 S. Enteritidis) showed
that only 6.8% of S. Typhimurium OAg were not O-acetylated, compared with 35.6% and
Table 1. Number of study NTS isolates by serovar and origin.
S. Typhimurium (% of total S. Typhimurium, n = 114) S. Enteritidis (% of total S. Enteritidis,
n = 78)
Total (%
of total
NTS)
blood Stool blood & stool urine CSF Soil Sewer water ND blood Stool blood & stool ND
Invasive 48
(42%)
− 7 (6%) 3
(3%)
2
(2%)
− − 22
(28%)
− 5 (6%) − 87 (45%)
Gastrointestinal − 24
(21%)
− − − − − − − 32
(41%)
− − 56 (29%)
Healthy
carriers
− 21
(18%)
− − − − − − − 10
(13%)
− − 31 (16%)
Environmental − − − − − 1
(1%)
1 (1%) − − − − − 2 (1%)
ND − − − − − − − 7
(6%)
− − − 9
(12%)
16 (8%)
Total 114 78 192
ND = Isolates for which no documentation on clinical form was available; n = Total number
Gastrointestinal and healthy carrier isolates were derived from stool samples.
doi:10.1371/journal.pntd.0003573.t001
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42.2% of S. Enteritidis OAg with no or traces of O-acetyl groups, respectively. For S. Typhimur-
ium, OAg, O-acetylation was detected on both rhamnose (Rha) and abequose (Abe) sugar resi-
dues in the majority of isolates (63%), but also on Rha only (9.6%) and Abe only (17.8%)
(Table 2; Fig. 3b and c; see S3a Table for supporting information). HPAEC-PAD was done on a
subset of 91 isolates (55 S. Typhimurium and 36 SEn) and showed that for both serovars, the
majority of strains (72.2%) expressed OAg with 20–50% glucosylation levels (Fig. 3d, see
S3b Table for supporting information).
Analysis of associations between clinical presentation and bacterial
characteristics
SBA results, OAg features and clinical presentation were compared. As mentioned above, there
was a clear inter-serovar difference, with S. Enteritidis isolates having more OAg than S. Typhi-
murium and being more resistant to antibody-mediated killing than S. Typhimurium. Among
S. Typhimurium isolates, there was a correlation between amount of OAg and resistance to
antibody-mediated killing (Spearman r = 0.29, 95% CI 0.10 to 0.45, p = 0.002) in accordance
with our initial hypothesis, but this was not present for S. Enteritidis (Fig. 4).
No correlation was found between NTS clinical presentation (invasive, gastrointestinal
and carrier) and either antibody susceptibility or polysaccharide production, for either S.
Typhimurium or S. Enteritidis isolates (Fig. 5). There was no clear correlation between
O-acetylation levels/position and glucosylation levels with clinical presentation, antibody
susceptibility and OAg production. For S. Typhimurium, we found an association between
Fig 1. SBA results of STm and SEn isolates with Malawi serum pool. Bacterial colony forming units (CFU) were counted at time 0 (T0) and after 3 h
(T180) incubation of bacteria in 45 μL undiluted serum (final bacterial concentration 1×106 CFU/ml). Killing/growth was determined by Log10 (CFU at T180)-
Log10 (CFU at T0). Strains that could grow (Log10 change>0) were considered “resistant”, strains that were killed (Log10 change<0) were considered
susceptible. Dashed/continuous line indicates median Log10 change of STm (-2.9) and SEn (-1.2) isolates, respectively.
doi:10.1371/journal.pntd.0003573.g001
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lower glucosylation levels and higher OAg production (Spearman r = 0.51, 95% CI-0.69 to-
0.27, p value<0.001) (Fig. 6).
Discussion
NTS infections are a major problem in sub-Saharan Africa and can either present as bacterae-
mia, with symptoms of gastroenteritis in under half of patients, or as diarrheal disease without
bloodstream infection [1,11,37]. Both presentations can be life-threatening, with case fatality
rates of 20–25% for iNTS bacteremia in children [1,2,8,10] and up to 50% in HIV-infected
adults [9], and a recognized association between NTS diarrhoea with mortality [16]. No vac-
cine is currently available.
The main finding of the study is that all isolates studied, apart from one S. Typhimurium,
were susceptible to antibody-dependent complement-mediated killing, using a serum pool
from an endemic region. Previously it has been shown that the antibody response specific to
NTS is acquired with age, corresponding with a decline in cases of NTS bacteraemia [26,38].
The serum pool we used contained high levels of anti-OAg (both S. Typhimurium and S.
Enteritidis) antibodies as expected among healthy adults in a Salmonella endemic region of
sub-Saharan Africa such as Kenya, Malawi or Tanzania [32]. The study therefore confirms the
bactericidal activity of anti-Salmonella antibodies against the vast majority of endemic NTS
isolates in the current study. These findings support an important role for antibodies in protec-
tive vaccines against iNTS disease [31,33,39].
Another key finding is the difference in relationship between susceptibility to antibody-
mediated killing and levels of OAg expression for the two Salmonella serovars studied. Accord-
ing to our study hypothesis, decreased susceptibility of S. Enteritidis compared with S. Typhi-
murium could be the result of higher levels of OAg, not excluding the contributions of other
Fig 2. OAg production of S. Typhimurium (STm) and S. Enteritidis (SEn) isolates after growth and normalization to the same final OD: 35.Dashed/
continuous line indicates median OAg production of S. Typhimurium (STm) (14.4 μg/ml/OD) and S. Enteritidis (SEn) (16.8 μg/ml/OD) isolates, respectively.
doi:10.1371/journal.pntd.0003573.g002
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Fig 3. a) HPLC-SEC profile of S. Typhimurium Ke212 OAg (similar profiles obtained for all NTS strains; b) 1H NMR of S. Enteritidis Ke189 OAg and
c) S. Typhimurium Ke004 OAg (arrows indicate O-acetyl groups); d) HPAEC-PAD profile of S. TyphimuriumKe012 OAg sample indicating typical
sugars of the repeating unit (Rha, Gal, Glc and Man) and of the core region (Gal, Glc and NAcGlc) (similar profiles obtained for all NTS strains).
doi:10.1371/journal.pntd.0003573.g003
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pathogen features, not investigated here. A previous report fromMalaysia found that S. Enteri-
tidis isolates were more often isolated from the blood than stool of patients compared with
other Salmonella serovars [40], but the reasons for this were not explored. Considering that
OAg length and density play a role in pathogen virulence [27], increased levels of OAg expres-
sion may enhance the ability of S. Enteritidis isolates to evade host first line defence mecha-
nisms and gain access to the bloodstream. It has also been reported that, when exposed to
serum, S. Typhimurium upregulates genes for increased production of very long chain OAg to
escape complement-dependent killing [28]. Our finding of a correlation between OAg expres-
sion and resistance to antibody-mediated killing among S. Typhimurium isolates is consistent
with the hypothesis that high OAg expression protects against such killing. It is also well know
that strains lacking OAg are rapidly eliminated from the host [41,42], and there were no such
isolates in our collection. However, the lack of correlation between OAg expressed by S. Enteri-
tidis isolates and susceptibility to antibody-mediated killing does not support our hypothesis
for this serovar concerning OAg levels and resistance to antibody killing. This finding suggests
that other inherent factors of Salmonella, particularly S. Enteritidis, have a role in determining
loss of sensitivity. In other words, quantity of OAg is more important for resistance to
antibody-killing of S. Typhimurium than S. Enteritidis. Further studies are required to better
understand the factors contributing to the inherent resistance of S. Enteritidis.
In relation to OAg fine specificity (O-acetylation) of the isolates in our collection, S. Typhi-
murium were more heterogeneous than S. Enteritidis. OAg O-acetylation occurred in almost
all S. Typhimurium isolates, and most often at two different sites: C-2 Abe (known to provide
factor O:5 specificity) and C-2/C-3 Rha. Rha O-acetylation was first reported by Wollin et al
[43] and we have previously reported this as part of the characterisation of an invasive Mala-
wian S. Typhimurium isolate [44]. The extent to which this additional O-acetylation was wide-
spread in our collection suggests a possible role in pathogenesis that should be investigated
further. Moreover, the fact that we could also identify S. Typhimurium isolates with either
Abe- or Rha-O-acetylation only, shows that O-acetylation at both sites can occur independent-
ly. A S. Typhimurium OAg-based vaccine for Africa would need to induce antibodies capable
of binding to both OAg specificities. In contrast, O-acetylation of S. Enteritidis OAg was not as
common, with more than two-thirds of the isolates lacking or having very low levels of
O-acetylation.
Glucosylation is another OAg modification for which variation has been described for S.
Typhimurium and can occur on the O:12 antigen galactose (C4 position) generating the 12–2
variant, and on the O:1 antigen galactose (C6 position) (phage-determined) [45]. It has been
Table 2. Proportion distribution in percentages of O-acetylation and glucosylation levels among NTS isolates.
O-Acetylation (n = 73 S. Typhimurium, 44 S. Enteritidis) Glucosylation (n = 55 S.
Typhimurium, 36 S.
Enteritidis)
% strains with O-acetyl groups % strains with traces or no O-acetyl groups % strains with
glucosylation level
On both Rha &
Abe
On Abe
only
On Rha
only
With traces of O-acetyl
groups
No O-acetyl
groups
<20% 20–50% >50%
S. Typhimurium 63.0 17.8 9.6 3.0 6.8 29.1 56.4 14.5
S. Enteritidis 22.2 42.2 35.6 13.9 72.2 13.9
n = Total number; Rha = rhamnose; Abe = abequose
doi:10.1371/journal.pntd.0003573.t002
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Fig 4. Correlation of SBA results and OAg production levels in (a) S. Typhimurium isolates (p = 0.002)
and (b) S. Enteritidis isolates (p = 0.637). r is the Spearman correlation coefficient. CI is confidence interval.
doi:10.1371/journal.pntd.0003573.g004
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reported that O:12 glucosylation in Typhimurium is not constitutive, occurs during intracellu-
lar macrophage growth and is associated with enhanced intestinal colonization [46]. All S.
Typhimurium isolates in our collection were glucosylated, with less than 30% of them at levels
< 20%, showing that glucosylation is a very common feature among endemic strains. Similarly,
86% S. Enteritidis isolates investigated showed a glucosylation level>20%. Glucosylation in S.
Enteritidis is not associated with specific OAg factors and it has not been extensively studied. A
report on S. Enteritidis food-borne salmonellosis strains showed glucosylated LPS in some
mouse isolates, closely related to strains obtained from eggs [47], but not in archived S.
Enteritidis strains.
In Shigella, LPS glucosylation promotes bacterial invasion by enhancing type III secretion
system (T3SS) function and is associated with reduced LPS chain length [48]. In Salmonella,
T3SS is necessary for invasion of intestinal epithelium and survival within macrophages and
further investigation into different glucosylation levels and T3SS-mediated invasion is still to
be performed. The inverse correlation between S. Typhimurium OAg glucosylation and OAg
expression observed in the current study may be related to T3SS function, as previously re-
ported for Shigella [48] and S. Typhimurium [30]. Salmonella isolates defective for the synthe-
sis of long and very long OAg species have been shown to have increased translocation of a
Fig 5. Correlation of SBA results (a, c) and OAg production levels (b, d) in S. Typhimurium (a, b) and S. Enteritidis (c, d) isolates with clinical
presentations. Samples for which no clinical presentation was determined were excluded from analysis. Malawi serum pool was used for SBA. Invasive:
Salmonella isolates from blood, urine, CSF. Gastrointestinal: Salmonella isolates from stools. Controls: Salmonella isolates from stools of healthy controls.
doi:10.1371/journal.pntd.0003573.g005
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Salmonella pathogenicity island 1 (SPI1)-T3SS effector protein promoting invasion. Therefore,
also for Salmonella, there may be the need to balance T3SS activity, possibly enhanced by
shorter and glucosylated LPS, and protection against innate immune effectors, which is fa-
voured by a thicker LPS layer [27,28].
The reasons for NTS disease presenting as invasive or enteric disease are not well under-
stood and could relate to host immunity and/or pathogen virulence. Epidemiological data indi-
cate a frequent presentation of the invasive syndrome, without diarrhoea symptoms, in
younger age groups [49], often associated with other infections such as malaria and HIV [50–
52]. However, specific investigations on the relationship between invasive and diarrheal disease
are extremely limited, partially due to the limited microbiological resources in endemic African
countries and few data are available on contemporaneous presence of NTS in stool and blood
samples [53]. Another problem is that the concentration of Salmonella in the blood of bacterae-
mic patients can be as low as 1 CFU/ml [54] and blood culture sensitivity is estimated to be
about 50% [54].
The lack of obvious difference between phenotype of NTS isolates from invasive and gastro-
intestinal disease episodes is consistent with the concept that invasive NTS isolates are able to
cause diarrhoea and vice versa. If true, this would implicate host immunity as the major deter-
minant of NTS disease presentation in endemic sub-Saharan African countries. Other previous
Fig 6. Correlation of S. Typhimurium (STm) OAg production levels and glucosylation (p<0.0001). r is the Spearman correlation coefficient. CI is
confidence interval.
doi:10.1371/journal.pntd.0003573.g006
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studies [49] have not managed to identify specific pathogen determinants for either invasive or
gastrointestinal syndromes, therefore the interplay between host and pathogen may be key.
There are several limitations to the current study: categorization of isolates as “invasive” or
“gastroenteric” was based on clinical presentation, as confirmed by microbiological analysis.
Blood and stool samples belonging to the same patient were rarely collected, making it impossi-
ble to exclude that bacteria from bacteremic patients were not also present in stool and vice
versa [53]. Another limitation was the lack of patients’ outcome data, which could give further
insights into possible differences in serovar- and isolate pathogenicity,
In summary, Kenyan NTS isolates from patients with bacteraemia and gastroenteritis were
susceptible to antibody-mediated killing, supporting the development of an antibody-inducing
vaccine against NTS for Africa. S. Enteritidis were generally less susceptible to killing than S.
Typhimurium isolates and expressed higher levels of OAg, but while OAg expression correlat-
ed with antibody resistance for S. Typhimurium isolates, no correlation could be found for S.
Enteritidis, supporting a role for other inherent bacterial factors in conferring resistance to an-
tibody killing for this Salmonella serogroup. Serovar- and strain-specific differences in OAg ex-
pression and fine specificity were found. Those features could not be correlated to clinical
presentation, so the same strains may be able to cause both invasive disease and diarrhoea.
Whole genome analysis of invasive and gastrointestinal NTS isolates from Africa will provide
additional insights regarding whether these strains are the same or different [53].
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